NYSE - Nasdaq Real Time Price USD

Solventum Corporation (SOLV)

Compare
67.07
-1.89
(-2.74%)
At close: January 10 at 4:00:02 PM EST
66.78
-0.29
(-0.43%)
After hours: 7:48:08 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Bryan C. Hanson CEO & Director -- -- 1967
Mr. Wayde D. McMillan Chief Financial Officer -- -- 1970
Ms. Mary T. Wilcox Senior VP, Controller & Chief Accounting Officer -- -- 1964
Ms. Amy Landucci Chief Information & Digital Officer -- -- 1975
Ms. Marcela A. Kirberger Chief Legal Affairs Officer & Corporate Secretary -- -- 1967
Mr. Sanjiv Arora Chief Strategy & Corporate Development Officer -- -- 1966
Ms. Tammy L. Gomez Chief Human Resources Officer -- -- 1972
Mr. Paul S. Harrington Chief Supply Chain Officer -- -- 1969
Mr. Karim Mansour President of Dental Solutions -- -- --
Ms. Garri Garrison President of Health Information Systems -- -- --

Solventum Corporation

3M Center
Building 275-6W 2510 Conway Avenue East
Saint Paul, MN 55144
United States
651-733-1110 https://www.solventum.com
Sector: 
Healthcare

Description

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Corporate Governance

Solventum Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 7, 2024 at 9:05 PM UTC

Solventum Corporation Earnings Date

Recent Events

December 11, 2024 at 12:00 AM UTC

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

December 4, 2024 at 4:30 PM UTC

at Piper Sandler Healthcare Conference

November 26, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 19, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 15, 2024 at 12:00 AM UTC

S-4: Offering Registrations

November 8, 2024 at 12:00 AM UTC

IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

November 7, 2024 at 9:30 PM UTC

Q3 2024 Earnings Call

November 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 24, 2024 at 12:00 AM UTC

SC 13G: Tender Offer/Acquisition Reports

Related Tickers